Nanashima Atsushi, Yamaguchi Hiroyuki, Sumida Yorihisa, Abo Takafumi, Tobinaga Syuuichi, Tanaka Kenji, Takeshita Hiroaki, Hidaka Shigekazu, Sawai Terumitsu, Yasutake Toru, Nagayasu Takeshi
Division of Surgical Oncology, Department of Translational Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Hepatogastroenterology. 2008 May-Jun;55(84):873-8.
BACKGROUND/AIMS: In advanced cancers of hepatobiliary and pancreatic lesions, major vascular resection and reconstruction are necessary to accomplish curative resection, which may provide better patient outcomes.
Surgical records, morbidity and mortality, and prognosis were examined in patients with combined vascular resection. Thirty-six patients underwent 18 hepatectomies and 18 pancreatectomies.
In 18 patients who underwent hepatic resection, the resected vessels were the portal vein (PV) in 10, vena cava or hepatic vein in 9 and right hepatic artery (RHA) in 3. An artificial graft was used in 2 to replace the vena cava. Vascular bypass was performed in 5 patients. Morbidity was due to biliary stricture in 1 patient and adult respiratory distress syndrome in another who died during hospital stay. Fourteen (82%) had cancer recurrence, of whom 12 died of cancer, one died of other disease, and 2 survived cancer-free. The 5-year survival was 28%. In 18 patients who underwent pancreatectomy, resected vessels were PV in 18 and RHA in 1. An artificial graft was used in 3 and vascular passive bypass was performed in 6. One patient died of sepsis after total pancreatectomy during hospital stay. Eleven (64%) had cancer recurrence, of whom 11 died of cancer, 2 died of other disease, and 4 survived cancer-free. The 3-year survival was 27%.
Complete surgical resection (R0) combined with main vascular resection could be safely performed in many patients with disease of the hepatobiliary and pancreas, which achieved longer survival in some patients even in the advanced stage.
背景/目的:在晚期肝胆胰病变癌症中,为实现根治性切除,进行主要血管切除和重建是必要的,这可能会为患者带来更好的预后。
对接受联合血管切除的患者的手术记录、发病率、死亡率和预后进行了检查。36例患者接受了18例肝切除术和18例胰腺切除术。
在接受肝切除的18例患者中,切除的血管为门静脉(PV)10例、腔静脉或肝静脉9例、右肝动脉(RHA)3例。2例使用人工移植物替代腔静脉。5例患者进行了血管搭桥。1例患者因胆道狭窄发病,另1例在住院期间死于成人呼吸窘迫综合征。14例(82%)出现癌症复发,其中12例死于癌症,1例死于其他疾病,2例无癌生存。5年生存率为28%。在接受胰腺切除的18例患者中,切除的血管为PV 18例、RHA 1例。3例使用人工移植物,6例进行了血管被动搭桥。1例患者在全胰切除术后住院期间死于败血症。11例(64%)出现癌症复发,其中11例死于癌症,2例死于其他疾病,4例无癌生存。3年生存率为27%。
许多肝胆胰疾病患者可安全地进行完整的手术切除(R0)联合主要血管切除,即使在晚期,部分患者也能获得更长的生存期。